International Society for Pharmacoeconomics Outcomes Research
International Society for Pharmacoeconomics Outcomes Research reported $19.7 million in revenue and $19.4 million in expenses for calendar year 2024. Of every $100 it spent, $83.98 went to program services, $16.02 to management and general costs and $0.00 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 94.0% of the total. The highest compensation it reported for one person was $346,150 (CHIEF OPERATING OFFICER). 25 people received more than $100,000 in reportable compensation. Revenue rose 19% between 2019 and 2024. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $19MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $20MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 84.0% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 16.0% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | Not reported | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 0.0% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 94.0% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $346,150 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 1.79% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 25 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 15.9 | 13.3 |
| Independent voting board members Part VI 1a–1b | 11 of 11 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseIspor is a global, nonprofit scientific and educational society advancing excellence in health economics and outcomes research (heor) to improve healthcare decision-making worldwide.ispor has over 18,000 invidividual and chapter members across more than 100 countries who are involved in healthcare economics and outcomes research, including stakeholders from academia, government, payers, industry, healthcare providers, and patient organizations.ispor fosters the use of health economics and outcomes research for healthcare policy and decision-making worldwide with over 75 regional chapters and…
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| CHIEF OPERATING OFFICER Officer, 40.00 hrs/week | $317,919 | $0 | $28,231 | $346,150 |
| CHIEF SCIENCE OFFICER Highest compensated employee, 40.00 hrs/week | $318,549 | $0 | $12,273 | $330,822 |
| CHIEF MARKETING OFFICER Highest compensated employee, 40.00 hrs/week | $233,634 | $0 | $31,859 | $265,493 |
| DIRECTOR, BUSINESS DEVELOPMENT Highest compensated employee, 40.00 hrs/week | $222,811 | $0 | $36,692 | $259,503 |
| CHIEF INFO & ENGAGEMENT OFFICER Highest compensated employee, 40.00 hrs/week | $201,641 | $0 | $34,293 | $235,934 |
| DIRECTOR, GLOBAL EVENTS Highest compensated employee, 40.00 hrs/week | $204,550 | $0 | $21,913 | $226,463 |
25 people received more than $100,000 in reportable compensation from International Society for Pharmacoeconomics Outcomes Research (Part VII, line 2). Compensation of current officers, directors and key employees totaled $346K (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b11 · 11 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 569
- Volunteers Part I, line 61,000
Correct a figure or respond
Every number above is copied from International Society for Pharmacoeconomics Outcomes Research's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for International Society for Pharmacoeconomics Outcomes Research, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 International Society for Pharmacoeconomics Outcomes Research spent in 2024, $83.98 went to programs. The full breakdown, from its IRS Form 990:
Questions people ask
How much of International Society for Pharmacoeconomics Outcomes Research's spending goes to programs?
In calendar year 2024, International Society for Pharmacoeconomics Outcomes Research reported that 84.0% of its $19.4 million in expenses went to program services, 16.0% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does International Society for Pharmacoeconomics Outcomes Research pay its top executive?
The largest total compensation International Society for Pharmacoeconomics Outcomes Research reported for one person in calendar year 2024 was $346,150, for the role of CHIEF OPERATING OFFICER (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does International Society for Pharmacoeconomics Outcomes Research get its money?
Of $19.7 million in revenue in calendar year 2024, 0.0% came from contributions and grants and 94.0% from program service revenue (Form 990, Part VIII).
Is International Society for Pharmacoeconomics Outcomes Research a registered charity?
The IRS lists EIN 22-3369741 as a 501(c)(3) organization (publicly supported organization (509(a)(2))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202522629349300102 · read the filing
- 2023: Form 990 for calendar year 2023, object 202402429349300600 · read the filing
- 2022: Form 990 for calendar year 2022, object 202302519349301100 · read the filing
- 2021: Form 990 for calendar year 2021, object 202211869349300336 · read the filing
- 2020: Form 990 for calendar year 2020, object 202131889349300403 · read the filing
- 2019: Form 990 for calendar year 2019, object 202001719349300400 · read the filing
All filings for EIN 22-3369741: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.